NCT04679753View on ClinicalTrials.gov

Brainsway DTMS for Treatment of MDD Using iTBS

PHASE4CompletedINTERVENTIONAL
Enrollment

177

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

July 1, 2020

Study Completion Date

July 1, 2020

Conditions
Major Depressive Disorder
Interventions
DEVICE

Brainsway DTMS with intermittent Theta Burst Stimulation (iTBS)

Brainsway DTMS with iTBS

DEVICE

Brainsway DTMS with High Frequency (HF) Stimulation

Brainsway DTMS with HF

Trial Locations (1)

S3N 4C6

SynapseTMS, Yorkton

Sponsors

Lead Sponsor

Brainsway
All Listed Sponsors
lead

Brainsway

INDUSTRY

NCT04679753 - Brainsway DTMS for Treatment of MDD Using iTBS | Biotech Hunter | Biotech Hunter